- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
According to our latest study, the global Liraglutide market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Liraglutide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Liraglutide market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Liraglutide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Liraglutide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Liraglutide market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liraglutide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liraglutide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology and Shenzhen JYMed Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Liraglutide market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pills
Liquid
Market segment by Application
Hospital
Drug Store
Major players covered
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liraglutide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Liraglutide, with price, sales, revenue and global market share of Liraglutide from 2018 to 2023.
Chapter 3, the Liraglutide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liraglutide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Liraglutide market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Liraglutide.
Chapter 14 and 15, to describe Liraglutide sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Liraglutide
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Liraglutide Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pills
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Liraglutide Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Drug Store
1.5 Global Liraglutide Market Size & Forecast
1.5.1 Global Liraglutide Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Liraglutide Sales Quantity (2018-2029)
1.5.3 Global Liraglutide Average Price (2018-2029)
2 Manufacturers Profiles
2.1 HEC Pharm
2.1.1 HEC Pharm Details
2.1.2 HEC Pharm Major Business
2.1.3 HEC Pharm Liraglutide Product and Services
2.1.4 HEC Pharm Liraglutide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 HEC Pharm Recent Developments/Updates
2.2 Bachem
2.2.1 Bachem Details
2.2.2 Bachem Major Business
2.2.3 Bachem Liraglutide Product and Services
2.2.4 Bachem Liraglutide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bachem Recent Developments/Updates
2.3 Bharat Pharmaceuticals
2.3.1 Bharat Pharmaceuticals Details
2.3.2 Bharat Pharmaceuticals Major Business
2.3.3 Bharat Pharmaceuticals Liraglutide Product and Services
2.3.4 Bharat Pharmaceuticals Liraglutide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bharat Pharmaceuticals Recent Developments/Updates
2.4 Kingpep Biotechnology
2.4.1 Kingpep Biotechnology Details
2.4.2 Kingpep Biotechnology Major Business
2.4.3 Kingpep Biotechnology Liraglutide Product and Services
2.4.4 Kingpep Biotechnology Liraglutide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kingpep Biotechnology Recent Developments/Updates
2.5 Shenzhen JYMed Technology
2.5.1 Shenzhen JYMed Technology Details
2.5.2 Shenzhen JYMed Technology Major Business
2.5.3 Shenzhen JYMed Technology Liraglutide Product and Services
2.5.4 Shenzhen JYMed Technology Liraglutide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Shenzhen JYMed Technology Recent Developments/Updates
2.6 Wuxi Asiapeptide
2.6.1 Wuxi Asiapeptide Details
2.6.2 Wuxi Asiapeptide Major Business
2.6.3 Wuxi Asiapeptide Liraglutide Product and Services
2.6.4 Wuxi Asiapeptide Liraglutide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Wuxi Asiapeptide Recent Developments/Updates
2.7 AmbioPharm
2.7.1 AmbioPharm Details
2.7.2 AmbioPharm Major Business
2.7.3 AmbioPharm Liraglutide Product and Services
2.7.4 AmbioPharm Liraglutide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AmbioPharm Recent Developments/Updates
3 Competitive Environment: Liraglutide by Manufacturer
3.1 Global Liraglutide Sales Quantity by Manufacturer (2018-2023)
3.2 Global Liraglutide Revenue by Manufacturer (2018-2023)
3.3 Global Liraglutide Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Liraglutide by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Liraglutide Manufacturer Market Share in 2022
3.4.2 Top 6 Liraglutide Manufacturer Market Share in 2022
3.5 Liraglutide Market: Overall Company Footprint Analysis
3.5.1 Liraglutide Market: Region Footprint
3.5.2 Liraglutide Market: Company Product Type Footprint
3.5.3 Liraglutide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Liraglutide Market Size by Region
4.1.1 Global Liraglutide Sales Quantity by Region (2018-2029)
4.1.2 Global Liraglutide Consumption Value by Region (2018-2029)
4.1.3 Global Liraglutide Average Price by Region (2018-2029)
4.2 North America Liraglutide Consumption Value (2018-2029)
4.3 Europe Liraglutide Consumption Value (2018-2029)
4.4 Asia-Pacific Liraglutide Consumption Value (2018-2029)
4.5 South America Liraglutide Consumption Value (2018-2029)
4.6 Middle East and Africa Liraglutide Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Liraglutide Sales Quantity by Type (2018-2029)
5.2 Global Liraglutide Consumption Value by Type (2018-2029)
5.3 Global Liraglutide Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Liraglutide Sales Quantity by Application (2018-2029)
6.2 Global Liraglutide Consumption Value by Application (2018-2029)
6.3 Global Liraglutide Average Price by Application (2018-2029)
7 North America
7.1 North America Liraglutide Sales Quantity by Type (2018-2029)
7.2 North America Liraglutide Sales Quantity by Application (2018-2029)
7.3 North America Liraglutide Market Size by Country
7.3.1 North America Liraglutide Sales Quantity by Country (2018-2029)
7.3.2 North America Liraglutide Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Liraglutide Sales Quantity by Type (2018-2029)
8.2 Europe Liraglutide Sales Quantity by Application (2018-2029)
8.3 Europe Liraglutide Market Size by Country
8.3.1 Europe Liraglutide Sales Quantity by Country (2018-2029)
8.3.2 Europe Liraglutide Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Liraglutide Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Liraglutide Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Liraglutide Market Size by Region
9.3.1 Asia-Pacific Liraglutide Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Liraglutide Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Liraglutide Sales Quantity by Type (2018-2029)
10.2 South America Liraglutide Sales Quantity by Application (2018-2029)
10.3 South America Liraglutide Market Size by Country
10.3.1 South America Liraglutide Sales Quantity by Country (2018-2029)
10.3.2 South America Liraglutide Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Liraglutide Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Liraglutide Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Liraglutide Market Size by Country
11.3.1 Middle East & Africa Liraglutide Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Liraglutide Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Liraglutide Market Drivers
12.2 Liraglutide Market Restraints
12.3 Liraglutide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Liraglutide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Liraglutide
13.3 Liraglutide Production Process
13.4 Liraglutide Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Liraglutide Typical Distributors
14.3 Liraglutide Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Liraglutide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Liraglutide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. HEC Pharm Basic Information, Manufacturing Base and Competitors
Table 4. HEC Pharm Major Business
Table 5. HEC Pharm Liraglutide Product and Services
Table 6. HEC Pharm Liraglutide Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. HEC Pharm Recent Developments/Updates
Table 8. Bachem Basic Information, Manufacturing Base and Competitors
Table 9. Bachem Major Business
Table 10. Bachem Liraglutide Product and Services
Table 11. Bachem Liraglutide Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bachem Recent Developments/Updates
Table 13. Bharat Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Bharat Pharmaceuticals Major Business
Table 15. Bharat Pharmaceuticals Liraglutide Product and Services
Table 16. Bharat Pharmaceuticals Liraglutide Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bharat Pharmaceuticals Recent Developments/Updates
Table 18. Kingpep Biotechnology Basic Information, Manufacturing Base and Competitors
Table 19. Kingpep Biotechnology Major Business
Table 20. Kingpep Biotechnology Liraglutide Product and Services
Table 21. Kingpep Biotechnology Liraglutide Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Kingpep Biotechnology Recent Developments/Updates
Table 23. Shenzhen JYMed Technology Basic Information, Manufacturing Base and Competitors
Table 24. Shenzhen JYMed Technology Major Business
Table 25. Shenzhen JYMed Technology Liraglutide Product and Services
Table 26. Shenzhen JYMed Technology Liraglutide Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Shenzhen JYMed Technology Recent Developments/Updates
Table 28. Wuxi Asiapeptide Basic Information, Manufacturing Base and Competitors
Table 29. Wuxi Asiapeptide Major Business
Table 30. Wuxi Asiapeptide Liraglutide Product and Services
Table 31. Wuxi Asiapeptide Liraglutide Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Wuxi Asiapeptide Recent Developments/Updates
Table 33. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 34. AmbioPharm Major Business
Table 35. AmbioPharm Liraglutide Product and Services
Table 36. AmbioPharm Liraglutide Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. AmbioPharm Recent Developments/Updates
Table 38. Global Liraglutide Sales Quantity by Manufacturer (2018-2023) & (K MT)
Table 39. Global Liraglutide Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Liraglutide Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 41. Market Position of Manufacturers in Liraglutide, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Liraglutide Production Site of Key Manufacturer
Table 43. Liraglutide Market: Company Product Type Footprint
Table 44. Liraglutide Market: Company Product Application Footprint
Table 45. Liraglutide New Market Entrants and Barriers to Market Entry
Table 46. Liraglutide Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Liraglutide Sales Quantity by Region (2018-2023) & (K MT)
Table 48. Global Liraglutide Sales Quantity by Region (2024-2029) & (K MT)
Table 49. Global Liraglutide Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Liraglutide Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Liraglutide Average Price by Region (2018-2023) & (USD/MT)
Table 52. Global Liraglutide Average Price by Region (2024-2029) & (USD/MT)
Table 53. Global Liraglutide Sales Quantity by Type (2018-2023) & (K MT)
Table 54. Global Liraglutide Sales Quantity by Type (2024-2029) & (K MT)
Table 55. Global Liraglutide Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Liraglutide Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Liraglutide Average Price by Type (2018-2023) & (USD/MT)
Table 58. Global Liraglutide Average Price by Type (2024-2029) & (USD/MT)
Table 59. Global Liraglutide Sales Quantity by Application (2018-2023) & (K MT)
Table 60. Global Liraglutide Sales Quantity by Application (2024-2029) & (K MT)
Table 61. Global Liraglutide Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Liraglutide Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Liraglutide Average Price by Application (2018-2023) & (USD/MT)
Table 64. Global Liraglutide Average Price by Application (2024-2029) & (USD/MT)
Table 65. North America Liraglutide Sales Quantity by Type (2018-2023) & (K MT)
Table 66. North America Liraglutide Sales Quantity by Type (2024-2029) & (K MT)
Table 67. North America Liraglutide Sales Quantity by Application (2018-2023) & (K MT)
Table 68. North America Liraglutide Sales Quantity by Application (2024-2029) & (K MT)
Table 69. North America Liraglutide Sales Quantity by Country (2018-2023) & (K MT)
Table 70. North America Liraglutide Sales Quantity by Country (2024-2029) & (K MT)
Table 71. North America Liraglutide Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Liraglutide Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Liraglutide Sales Quantity by Type (2018-2023) & (K MT)
Table 74. Europe Liraglutide Sales Quantity by Type (2024-2029) & (K MT)
Table 75. Europe Liraglutide Sales Quantity by Application (2018-2023) & (K MT)
Table 76. Europe Liraglutide Sales Quantity by Application (2024-2029) & (K MT)
Table 77. Europe Liraglutide Sales Quantity by Country (2018-2023) & (K MT)
Table 78. Europe Liraglutide Sales Quantity by Country (2024-2029) & (K MT)
Table 79. Europe Liraglutide Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Liraglutide Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Liraglutide Sales Quantity by Type (2018-2023) & (K MT)
Table 82. Asia-Pacific Liraglutide Sales Quantity by Type (2024-2029) & (K MT)
Table 83. Asia-Pacific Liraglutide Sales Quantity by Application (2018-2023) & (K MT)
Table 84. Asia-Pacific Liraglutide Sales Quantity by Application (2024-2029) & (K MT)
Table 85. Asia-Pacific Liraglutide Sales Quantity by Region (2018-2023) & (K MT)
Table 86. Asia-Pacific Liraglutide Sales Quantity by Region (2024-2029) & (K MT)
Table 87. Asia-Pacific Liraglutide Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Liraglutide Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Liraglutide Sales Quantity by Type (2018-2023) & (K MT)
Table 90. South America Liraglutide Sales Quantity by Type (2024-2029) & (K MT)
Table 91. South America Liraglutide Sales Quantity by Application (2018-2023) & (K MT)
Table 92. South America Liraglutide Sales Quantity by Application (2024-2029) & (K MT)
Table 93. South America Liraglutide Sales Quantity by Country (2018-2023) & (K MT)
Table 94. South America Liraglutide Sales Quantity by Country (2024-2029) & (K MT)
Table 95. South America Liraglutide Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Liraglutide Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Liraglutide Sales Quantity by Type (2018-2023) & (K MT)
Table 98. Middle East & Africa Liraglutide Sales Quantity by Type (2024-2029) & (K MT)
Table 99. Middle East & Africa Liraglutide Sales Quantity by Application (2018-2023) & (K MT)
Table 100. Middle East & Africa Liraglutide Sales Quantity by Application (2024-2029) & (K MT)
Table 101. Middle East & Africa Liraglutide Sales Quantity by Region (2018-2023) & (K MT)
Table 102. Middle East & Africa Liraglutide Sales Quantity by Region (2024-2029) & (K MT)
Table 103. Middle East & Africa Liraglutide Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Liraglutide Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Liraglutide Raw Material
Table 106. Key Manufacturers of Liraglutide Raw Materials
Table 107. Liraglutide Typical Distributors
Table 108. Liraglutide Typical Customers
List of Figures
Figure 1. Liraglutide Picture
Figure 2. Global Liraglutide Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Liraglutide Consumption Value Market Share by Type in 2022
Figure 4. Pills Examples
Figure 5. Liquid Examples
Figure 6. Global Liraglutide Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Liraglutide Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Drug Store Examples
Figure 10. Global Liraglutide Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Liraglutide Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Liraglutide Sales Quantity (2018-2029) & (K MT)
Figure 13. Global Liraglutide Average Price (2018-2029) & (USD/MT)
Figure 14. Global Liraglutide Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Liraglutide Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Liraglutide by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Liraglutide Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Liraglutide Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Liraglutide Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Liraglutide Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Liraglutide Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Liraglutide Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Liraglutide Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Liraglutide Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Liraglutide Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Liraglutide Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Liraglutide Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Liraglutide Average Price by Type (2018-2029) & (USD/MT)
Figure 29. Global Liraglutide Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Liraglutide Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Liraglutide Average Price by Application (2018-2029) & (USD/MT)
Figure 32. North America Liraglutide Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Liraglutide Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Liraglutide Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Liraglutide Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Liraglutide Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Liraglutide Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Liraglutide Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Liraglutide Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Liraglutide Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Liraglutide Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Liraglutide Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Liraglutide Consumption Value Market Share by Region (2018-2029)
Figure 52. China Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Liraglutide Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Liraglutide Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Liraglutide Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Liraglutide Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Liraglutide Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Liraglutide Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Liraglutide Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Liraglutide Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Liraglutide Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Liraglutide Market Drivers
Figure 73. Liraglutide Market Restraints
Figure 74. Liraglutide Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Liraglutide in 2022
Figure 77. Manufacturing Process Analysis of Liraglutide
Figure 78. Liraglutide Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
